HUP9800520A2 - Génexpresszió emlős sejtekben - Google Patents

Génexpresszió emlős sejtekben

Info

Publication number
HUP9800520A2
HUP9800520A2 HU9800520A HUP9800520A HUP9800520A2 HU P9800520 A2 HUP9800520 A2 HU P9800520A2 HU 9800520 A HU9800520 A HU 9800520A HU P9800520 A HUP9800520 A HU P9800520A HU P9800520 A2 HUP9800520 A2 HU P9800520A2
Authority
HU
Hungary
Prior art keywords
proteins
hüman
vectors
various
genes
Prior art date
Application number
HU9800520A
Other languages
English (en)
Inventor
Wanjin Hong
Yin Hwee Tan
Original Assignee
Institute Of Molecular And Cell Biology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute Of Molecular And Cell Biology filed Critical Institute Of Molecular And Cell Biology
Publication of HUP9800520A2 publication Critical patent/HUP9800520A2/hu
Publication of HUP9800520A3 publication Critical patent/HUP9800520A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/60—Vector systems having a special element relevant for transcription from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A találmány tárgyát különböző gének emlős sejtekben történőexpresszáltatására alkalmas vektőrők képezik. A találmány szerintivektőrők közelebbről őlyan fehérjékért felelős génekexpresszáltatására alkalmasak, amelyek in vivő biőlógiai aktivitásátkülönöböző faktőrők befőlyásőlják, beleértve a specifikűsglikőzilációt. Ilyen gének példáűl a hűmán -interferőn (IFN), a hűmáneritrőpőietin (EPO), a hűmán chőriőnikűs gőnadőtrőpin, különböző máscitőkinek és növekedési faktőrők épp úgy, mint egyes vírűseredetűantigének, mint példáűl Dengűe vírűsfehérjék, amelyek szerkezetelényeges lehet az őltóanyagők kifejlesztésében. A találmány tárgyát képezik tővábbá a találmány szerinti vektőrőkkaltranszfőrmált sejtek, eljárásők a találmány szerinti sejtek és kívántfehérjék előállítására, a találmány szerinti vektőrőkkal transzfőrmáltsejtek, eljárásők a találmány szerinti eljárással előállítőttfehérjék, valamint a találmány szerinti fehérjéket tartalmazógyógyászati készítmények. A találmány szerinti megőldás alkalmasbizőnyős gyógyászatilag főntős hűmán fehérjék hatékőny előállítására. ŕ
HU9800520A 1995-03-24 1996-03-22 Gene expression in mammalian cells HUP9800520A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9506051.3A GB9506051D0 (en) 1995-03-24 1995-03-24 Gene expression

Publications (2)

Publication Number Publication Date
HUP9800520A2 true HUP9800520A2 (hu) 1998-06-29
HUP9800520A3 HUP9800520A3 (en) 1999-09-28

Family

ID=10771834

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9800520A HUP9800520A3 (en) 1995-03-24 1996-03-22 Gene expression in mammalian cells

Country Status (16)

Country Link
US (1) US6207146B1 (hu)
EP (1) EP0815251A1 (hu)
JP (1) JPH11502705A (hu)
KR (1) KR19980703275A (hu)
CN (1) CN1185180A (hu)
AP (1) AP730A (hu)
AU (1) AU722341B2 (hu)
BR (1) BR9607831A (hu)
CA (1) CA2216174A1 (hu)
GB (2) GB9506051D0 (hu)
HK (1) HK1005248A1 (hu)
HU (1) HUP9800520A3 (hu)
IL (1) IL117594A (hu)
NO (1) NO974367L (hu)
NZ (1) NZ303133A (hu)
WO (1) WO1996030531A1 (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002089828A2 (en) * 2001-05-04 2002-11-14 Institute Of Molecular And Cell Biology Interferons in the treatment of ischemia
FR2843973B1 (fr) * 2002-08-30 2006-07-07 Agronomique Inst Nat Rech Cassettes d'expression procaryotes regulees par le zinc
GB0524782D0 (en) * 2005-12-05 2006-01-11 Chiron Srl Analysis of samples
CN100432230C (zh) * 2006-05-11 2008-11-12 南京大学 一种金属硫蛋白融合表达方法及其应用
US8936936B2 (en) * 2007-10-25 2015-01-20 Sangamo Biosciences, Inc. Methods and compositions for targeted integration
SG11202009009UA (en) * 2018-03-21 2020-10-29 Nature Tech Corporation Viral and non-viral nanoplasmid vectors with improved production

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5514567A (en) 1979-01-30 1996-05-07 Juridical Foundation, Japanese Foundation For Cancer Research DNA and recombinant plasmid
AU538665B2 (en) 1979-10-30 1984-08-23 Juridical Foundation, Japanese Foundation For Cancer Research Human interferon dna
US4966843A (en) 1982-11-01 1990-10-30 Cetus Corporation Expression of interferon genes in Chinese hamster ovary cells
WO1986004920A1 (en) * 1985-02-13 1986-08-28 Biotechnology Research Partners, Limited Human metallothionein-ii promoter in mammalian expression system
GB2177914B (en) 1985-06-04 1989-10-25 Chugai Pharmaceutical Co Ltd A pharmaceutical composition containing human erythropoietin and a surface active agent for nasal administration for the treatment of anemia
US4954437A (en) * 1986-09-15 1990-09-04 Integrated Genetics, Inc. Cell encoding recombinant human erythropoietin
CA1294215C (en) * 1986-10-27 1992-01-14 Ze'ev Shaked Pharmaceutical compositions of recombinant beta-interferon and formulation processes
DE3712564A1 (de) 1987-04-14 1988-11-24 Bioferon Biochem Substanz Verfahren zur konstruktion einer animalen zellinie fuer die herstellung von humanem interferon-beta
DD287531A5 (de) * 1988-06-16 1991-02-28 Akademie Der Wissenschaften,De Verfahren zur herstellung von humanem wachstumshormon (sth) in tierischen zellen
DE4128319A1 (de) * 1991-08-27 1993-03-04 Bioferon Biochem Substanz Neues rekombinantes human-ifn-beta, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zubereitungen
EP0551535A1 (en) * 1992-01-13 1993-07-21 SCLAVO S.p.A. Process for the purification of recombinant human beta interferon, beta interferon thus purified, and pharmaceutical compositions which contain them

Also Published As

Publication number Publication date
BR9607831A (pt) 1999-11-30
IL117594A (en) 2002-11-10
AP9701091A0 (en) 1997-10-31
EP0815251A1 (en) 1998-01-07
HUP9800520A3 (en) 1999-09-28
AU722341B2 (en) 2000-07-27
JPH11502705A (ja) 1999-03-09
GB2314332B (en) 1999-06-30
WO1996030531A1 (en) 1996-10-03
GB9720467D0 (en) 1997-11-26
CN1185180A (zh) 1998-06-17
IL117594A0 (en) 1996-07-23
GB9506051D0 (en) 1995-05-10
MX9707244A (es) 1998-08-30
NO974367D0 (no) 1997-09-22
NO974367L (no) 1997-11-24
NZ303133A (en) 1999-11-29
AP730A (en) 1999-02-04
KR19980703275A (ko) 1998-10-15
HK1005248A1 (en) 1998-12-31
US6207146B1 (en) 2001-03-27
CA2216174A1 (en) 1996-10-03
GB2314332A (en) 1997-12-24
AU4935896A (en) 1996-10-16

Similar Documents

Publication Publication Date Title
KR910015309A (ko) 종양괴사인자(tnf) 억제제 및 그 제조방법
DE69033584D1 (de) Stammzellenfaktor
GB8912330D0 (en) Live vaccines
AU2790292A (en) Viral recombinant vectors for expression in muscle cells
NL930040I1 (nl) Humaan immuun interferon
FI20010334A (fi) Granulosyyttipesäkkeitä stimuloivia polypeptidejä, niitä sisältävä farmaseuttinen koostumus, ja niiden lääketieteellinen käyttö
ATE188255T1 (de) Von blutplättchen abstammende biologisch aktive analoga eines wachstumsfaktors in eukaryotischen zellen
WO1988002406A3 (en) Methods of regulating metabolic stability of proteins
KR920702417A (ko) Tcf-ii의 아미노산 배열을 코드하는 dna를 함유한 플라스미드, 형질전환세포, 및 이것을 사용하여 생리 활성물질을 생산하는 방법
SE8703539L (sv) Artificiell gen och proteinprodukt
DK91389D0 (da) Kallikreiner, deres fremstilling og laegemidler indeholdende polypeptiderne
EP0067697B1 (en) Cell culture method
DK0386752T3 (da) Polypeptid og fremstilling heraf
HUP9800520A2 (hu) Génexpresszió emlős sejtekben
EP0287075A3 (en) Process for the construction of an animal cell line for the production of human beta-interferon
EP0397560A3 (en) Spheroidin dna isolate and recombinant entomopoxvirus expression vectors
ATE243741T1 (de) Zufuhr von genprodukten mittels mesangium-zellen
ES2078243T3 (es) Mejoras en o relativas a la expresion eucariotica.
DE69027466T2 (de) Achromobacter-Protease-I-Gen sowie Genprodukt
ATE276364T1 (de) Biologisches material zur herstellung pharmazeutischer zusammensetzungen zur behandlung von säugetieren
Bondarenko INCORPORATION OF METHIONINES INTO PROTEINS LYMPHOID SERIES CELLS IN LYMPHATIC NODULES OF DIFFERENT MATURITY DEGREE
JPH0491100A (ja) 新規糖タンパク質及びその製造方法
DK544789A (da) Transkaryot implantering